Business
Press Release Aug 03 2023
Zydus Lifesciences Limited has informed the Exchange regarding a press release dated August 03, 2023, titled "Zydus receives Final Approval from the USFDA for Indomethacin Suppository with Competitive Generic Therapy (CGT) designation".
About this update from Zydus Lifesciences Limited
[{"type":"text","content":" Zydus Lifesciences Limited has informed the Exchange regarding a press release dated August 03, 2023, titled \"Zydus receives Final Approval from the USFDA for Indomethacin Suppository with Competitive Generic Therapy (CGT) designation\". View Attachment","length":390,"tagName":"div"}]